Skip to main content Skip to main navigation Skip to search Skip to footer

Business Process Management for Life Sciences Industry

Business Process Management for Life Sciences Industry

Abstract

Clinical trial supply chains (CTSCs) have historically focused on logistics and compliance, not excellence in execution. There is the clinical side of the business and then the operational side, with an iron curtain in the middle. Not surprisingly, only 23% of 107 pharmaceutical and biotech companies rate their CTSC processes as extremely effective, according to a recent AMR Research study.

Excerpts from the Paper
BPM has been a feature of the enterprise technology market for the last three decades. Today, BPM is more pertinent than ever. The global  business  environment  is  increasingly  dynamic,  pushing organizations to evaluate technologies that can help them respond to  business  challenges. By  adopting BPM,  enterprises  can  boost their ability to support key business processes and derive a palpable competitive advantage. 

BPM spans both business and technical domains and caters to a bewildering array of user scenarios. Consequently, BPM requires a finely-tuned go-to-market approach that depends on the choice of market channel, the customer constituency targeted, and enterprise maturity levels and, of course, the target industry. Never the less, BPM  implementations  have  been  shown  to  reduce  the  cost  of application development up to tenfold and significantly lower the cost of process ownership.

DOWNLOAD THE WHITEPAPER

Contact Us
MAX CHARACTERS: 10,000

We will treat any information you submit with us as confidential. Please read our privacy statement for additional information.

We will treat any information you submit with us as confidential. Please read our privacy statement for additional information.